BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12572939)

  • 1. Treatment of canine parvoviral enteritis with interferon-omega in a placebo-controlled field trial.
    de Mari K; Maynard L; Eun HM; Lebreux B
    Vet Rec; 2003 Jan; 152(4):105-8. PubMed ID: 12572939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of canine parvoviral enteritis with interferon-omega in a placebo-controlled challenge trial.
    Martin V; Najbar W; Gueguen S; Grousson D; Eun HM; Lebreux B; Aubert A
    Vet Microbiol; 2002 Oct; 89(2-3):115-27. PubMed ID: 12243889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant bactericidal/permeability-increasing protein (rBPI21) for treatment of parvovirus enteritis: a randomized, double-blinded, placebo-controlled trial.
    Otto CM; Jackson CB; Rogell EJ; Prior RB; Ammons WS
    J Vet Intern Med; 2001; 15(4):355-60. PubMed ID: 11467593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of an outpatient protocol in the treatment of canine parvoviral enteritis.
    Venn EC; Preisner K; Boscan PL; Twedt DC; Sullivan LA
    J Vet Emerg Crit Care (San Antonio); 2017 Jan; 27(1):52-65. PubMed ID: 27918639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feline interferon-omega treatment on canine parvovirus infection.
    Minagawa T; Ishiwata K; Kajimoto T
    Vet Microbiol; 1999 Sep; 69(1-2):51-3. PubMed ID: 10515269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the Efficacy of Maropitant Versus Ondansetron in the Treatment of Dogs with Parvoviral Enteritis.
    Sullivan LA; Lenberg JP; Boscan P; Hackett TB; Twedt DC
    J Am Anim Hosp Assoc; 2018; 54(6):338-343. PubMed ID: 30272481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on leukocyte count and survival rate of dogs with parvoviral enteritis.
    Mischke R; Barth T; Wohlsein P; Rohn K; Nolte I
    Res Vet Sci; 2001 Jun; 70(3):221-5. PubMed ID: 11676617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and inflammatory response to antiviral treatments in dogs with parvoviral enteritis.
    Ulas N; Ozkanlar Y; Ozkanlar S; Timurkan MO; Aydin H
    J Vet Sci; 2024 Jan; 25(1):e11. PubMed ID: 38311324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of oseltamivir in the treatment of canine parvoviral enteritis.
    Savigny MR; Macintire DK
    J Vet Emerg Crit Care (San Antonio); 2010 Feb; 20(1):132-42. PubMed ID: 20230441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the use of antiemetic agents in dogs with parvoviral enteritis treated at a veterinary teaching hospital: 77 cases (1997-2000).
    Mantione NL; Otto CM
    J Am Vet Med Assoc; 2005 Dec; 227(11):1787-93. PubMed ID: 16342528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amelioration of oxidative stress using N-acetylcysteine in canine parvoviral enteritis.
    Gaykwad C; Garkhal J; Chethan GE; Nandi S; De UK
    J Vet Pharmacol Ther; 2018 Feb; 41(1):68-75. PubMed ID: 28703421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palatability and Clinical Effects of an Oral Recuperation Fluid During the Recovery of Dogs With Suspected Parvoviral Enteritis.
    Tenne R; Sullivan LA; Contreras ET; Olea-Popelka F; Twedt DC; Fankhauser J; Mastrianna L; Lappin MR
    Top Companion Anim Med; 2016 Jun; 31(2):68-72. PubMed ID: 27968756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical effects of the recombinant feline interferon-omega on experimental parvovirus infection in beagle dogs.
    Ishiwata K; Minagawa T; Kajimoto T
    J Vet Med Sci; 1998 Aug; 60(8):911-7. PubMed ID: 9764403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endotoxemia and tumor necrosis factor activity in dogs with naturally occurring parvoviral enteritis.
    Otto CM; Drobatz KJ; Soter C
    J Vet Intern Med; 1997; 11(2):65-70. PubMed ID: 9127292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of the paramunity inducer PIND-ORF in the treatment of canine parvovirus infection.
    Proksch AL; Unterer S; Truyen U; Hartmann K
    Vet J; 2014 Nov; 202(2):340-7. PubMed ID: 25218850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of a single dose of immune plasma for treatment of canine parvovirus infection.
    Bragg RF; Duffy AL; DeCecco FA; Chung DK; Green MT; Veir JK; Dow SW
    J Am Vet Med Assoc; 2012 Mar; 240(6):700-4. PubMed ID: 22380808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canine parvovirus.
    Goddard A; Leisewitz AL
    Vet Clin North Am Small Anim Pract; 2010 Nov; 40(6):1041-53. PubMed ID: 20933134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of the Canine Parvovirus 2c Subtype in Australian Dogs.
    Woolford L; Crocker P; Bobrowski H; Baker T; Hemmatzadeh F
    Viral Immunol; 2017 Jun; 30(5):371-376. PubMed ID: 28414634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on Canine Parvoviral Enteritis.
    Mazzaferro EM
    Vet Clin North Am Small Anim Pract; 2020 Nov; 50(6):1307-1325. PubMed ID: 32891439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a killed feline panleukopenia virus vaccine against canine parvoviral enteritis in dogs.
    Wierup M; Olson P; Hedhammar A; Klingeborn B; Karlsson KA
    Am J Vet Res; 1982 Dec; 43(12):2183-7. PubMed ID: 6299140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.